— Know what they know.
Not Investment Advice

SGEN NASDAQ

Seagen Inc.
1W: +0.0% 1M: +7.3% 3M: +6.1% 1Y: +72.9% 3Y: +15.6% 5Y: +321.2%
$228.74
Last traded 2023-12-22 — delisted
NASDAQ · Healthcare · Biotechnology · $43.2B mcap · 130M float · 1.26% daily turnover

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$2.0B +24.6% ▲
5Y CAGR: +32.4%
Gross Profit
$1.6B +22.9% ▲
5Y CAGR: +29.4%
Operating Income
-$613M +10.1% ▲
Net Income
-$610M +9.5% ▲
EPS (Diluted)
$-3.30 +10.8% ▲
EBITDA
-$624M +9.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$655M$917M$2.2B$1.6B$2.0B
YoY Growth+35.8%+40.0%+137.3%-27.6%+24.6%
Cost of Revenue$88M$44M$218M$312M$410M
Gross Profit$566M$873M$2.0B$1.3B$1.6B
Gross Margin86.5%95.2%90.0%80.2%79.1%
R&D Expenses$565M$719M$827M$1.2B$1.3B
SG&A Expenses$261M$374M$534M$716M$821M
Operating Expenses$826M$1.1B$1.4B$1.9B$2.2B
Operating Income-$260M-$221M$597M-$682M-$613M
Operating Margin-39.7%-24.1%27.4%-43.3%-31.2%
Interest Expense$0$0$0$0$0
Income Before Tax-$246M-$159M$616M-$676M-$602M
Tax Expense-$24M-$95M$2M-$1M$8M
Net Income-$223M-$63M$614M-$674M-$610M
Net Margin-34.0%-6.9%28.2%-42.8%-31.1%
EPS (Diluted)$-1.41$-0.38$3.37$-3.70$-3.30
EBITDA-$274M-$282M$578M-$688M-$624M
Shares Outstanding158M165M182M182M185M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms